GEOFF MCDONOUGH - 31 Oct 2025 Form 4 Insider Report for Generation Bio Co. (GBIO)

Role
Director
Signature
/s/ Shawna-Gay White, Attorney-in-Fact
Issuer symbol
GBIO
Transactions as of
31 Oct 2025
Net transactions value
-$1,614
Form type
4
Filing time
21 Nov 2025, 17:00:11 UTC
Previous filing
17 Oct 2025

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
MCDONOUGH GEOFF Director C/O GENERATION BIO CO., 301 BINNEY ST, CAMBRIDGE /s/ Shawna-Gay White, Attorney-in-Fact 21 Nov 2025 0001732701

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction GBIO Common Stock Options Exercise +659 +0.48% 137,495 31 Oct 2025 Direct F1, F2
transaction GBIO Common Stock Tax liability $1,614 -293 -0.21% $5.51 137,202 31 Oct 2025 Direct
holding GBIO Common Stock 22,646 31 Oct 2025 By 2018 Trust F3
holding GBIO Common Stock 27,500 31 Oct 2025 By 2020 Trust F4

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction GBIO Restricted Stock Units Options Exercise $0 -659 -25% $0.000000 1,977 31 Oct 2025 Common Stock 527 Direct F1, F2, F5
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Reflects an acceleration of vesting due to the reporting person's resignation as the Issuer's Chief Executive Officer & President.
F2 Each restricted stock unit represents the right to receive one share of the company's common stock.
F3 The securities are directly held by the McDonough Family 2018 Irrevocable Trust, or the 2018 Trust. The reporting person is the settlor of the 2018 Trust, Allison L. McDonough and David S. Grayzel are trustees for the 2018 Trust, and the 2018 Trust is for the benefit of Graeme and Owen McDonough. The reporting person may be deemed to beneficially own the shares of common stock owned by the 2018 Trust.
F4 The securities are directly held by the McDonough Family 2020 Irrevocable Trust, or the 2020 Trust. The reporting person is the settlor of the 2020 Trust, Allison L. McDonough and David S. Grayzel are trustees for the 2020 Trust, and the 2020 Trust is for the benefit of Allison, Graeme and Owen McDonough. The reporting person may be deemed to beneficially own the shares of common stock owned by the 2020 Trust.
F5 On January 20, 2023, the reporting person was granted 8,437 restricted stock units. The shares underlying the restricted stock units vest over two years, with 25% of the shares vesting on July 15, 2022 and the remaining shares vesting in equal quarterly installments thereafter.